Arrowstreet Capital
AGIO icon

Arrowstreet Capital’s Agios Pharmaceuticals AGIO Stock Holding History

Arrowstreet Capital’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.1M Buy
810,530
+560,069
+224% +$17M 0.01% 726
2026
Q1 		$8.47M Buy
+250,461
New +$7.1M ﹤0.01% 997
2015
Q3 		– Sell
-6,300
Closed -$700K – 1329
2015
Q2 		$700K Sell
6,300
-4,800
-43% -$517K ﹤0.01% 908
2015
Q1 		$1.05M Buy
+11,100
New +$1.24M 0.01% 707

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Arrowstreet Capital's AGIO Position: Q2 2026 in Review

Arrowstreet Capital increased its Agios Pharmaceuticals (AGIO) stake by 224% in Q2 2026, buying an estimated $17M and bringing the position to 810,530 shares worth $30.1M. The position accounts for 0.01% of the portfolio, ranked #726.

Arrowstreet Capital first reported a position in AGIO in Q1 2015 and has held it in 4 quarters since. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Arrowstreet Capital held 810,530 shares of Agios Pharmaceuticals worth $30.1M as of Q2 2026.
  • Arrowstreet Capital bought 560,069 Agios Pharmaceuticals shares in Q2 2026, an estimated $17M.
  • Agios Pharmaceuticals made up 0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #726 holding.
  • Arrowstreet Capital first reported a position in Agios Pharmaceuticals in Q1 2015 and has held it in 4 quarters since.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.